Budesonide for the Induction and Maintenance of Remission in Crohn’s Disease: Systematic Review and Meta-Analysis for the Cochrane Collaboration

BACKGROUND: Budesonide is an oral glucocorticoid designed for the treatment of inflammatory bowel disease (IBD) that may reduce systemic adverse events (AEs). This review examined the efficacy and safety of budesonide for the induction and maintenance of clinical remission in Crohn’s disease (CD). M...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Can Assoc Gastroenterol
Egile Nagusiak: Kuenzig, M Ellen, Rezaie, Ali, Kaplan, Gilaad G, Otley, Anthony R, Steinhart, A Hillary, Griffiths, Anne Marie, Benchimol, Eric I, Seow, Cynthia H
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2018
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6328928/
https://ncbi.nlm.nih.gov/pubmed/30656288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy018
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak